| Tender Number | 3802185 |
|---|---|
| Buyer | |
| Location | Multi city, Multi State |
| Awarded Value | ₹ 205,652 |
| Selected Bidder |
Atropine Sulphate 0 point 6 mg 1 ml Inj,Midazolam 5 mg 1 ml Inj,Paracetamol with cysteine HCL monohydrate Infusion 1000mg per 100ml,Fentanyl 50mcg per ml 10 ml Inj,Nor adrenaline Bitartrate 2 mg per ml 2 ml Inj,Lorazepam 2mg per ml 2 ml Inj,Ondansetron 2mg per ml 4 ml Inj,Tranexamic Acid 500 mg per 5ml Inj,Dopamine HCl 40 mg per ml 5ml Inj,Dobutamine HCl 250 mg 5 ml Inj,Streptokinase 15 Lac IU Inj,Frusemide 20 mg 2 ml Inj,Ranitidine HCl 50 mg 2 ml Inj,Metoclopramide HCl 5mg per ml 2ml Inj,Hyoscine Bromide Inj 20 mg per ml 1ml Inj,Atracurium 10 mg per ml 2 point 5 ml Inj,Glycopyrrolate 0 point 2 mg per ml 1ml Inj,Neostigmine 0 point 5 mg 1 ml Inj,Succinylchloline Chloride 50 mg per ml 2 ml Inj,Sodium Bicarbonate 7 point 5 percent amp of 10 ml,Calcium 9mg plus Calcium gluconate 50mg Inj for IV use 10 ml Injection,Ceftriaxone 1gm Inj,Gentamycin sulphate Inj IM IV 40mg per ml 2 ml Inj,Tetanus Toxoid Purified Absorbed vaccine 0 point 5ml,Cell Culture Rabies Vaccine Vial of 1ml,Human Rabies Immune Globulin 150 IU p
| AOC | Tue 25th November, 2025 |
|---|
| Document Name | Action |
|---|---|
| Tender Notice | Sign Up to Download |
Company Study
We evaluate your eligibility, strengths, certifications, and past performance to align with buyer requirements.
Competitor Analysis
We study likely bidders, past AOCs, pricing bands, and technical patterns to position your bid smartly.
Submission & JV Execution
We prepare compliant documents, set up JV agreements, and handle portal uploading end-to-end.
| # | Name | Value | Position | Status |
|---|---|---|---|---|
| 1 | KANDA ENTERPRISES | 205652.00 | L1 | Qualified |
| 2 | NUYOS HEALTHCARE PRIVATE LIMITED | 206778.24 | L2 | Qualified |
| 3 | SANMAK PHARMACEUTICALS PRIVATE LIMITED | 234172.00 | L3 | Qualified |
| 4 | KANDA ENTERPRISES | 205652.00 | L1 | Qualified |
| 5 | NUYOS HEALTHCARE PRIVATE LIMITED | 206778.24 | L2 | Qualified |
| 6 | SANMAK PHARMACEUTICALS PRIVATE LIMITED | 234172.00 | L3 | Qualified |
| 7 | KANDA ENTERPRISES | 205652.00 | L1 | Qualified |
| 8 | NUYOS HEALTHCARE PRIVATE LIMITED | 206778.24 | L2 | Qualified |
| 9 | SANMAK PHARMACEUTICALS PRIVATE LIMITED | 234172.00 | L3 | Qualified |
| 10 | KANDA ENTERPRISES | 205652.00 | L1 | Qualified |
| 11 | NUYOS HEALTHCARE PRIVATE LIMITED | 206778.24 | L2 | Qualified |
| 12 | SANMAK PHARMACEUTICALS PRIVATE LIMITED | 234172.00 | L3 | Qualified |
| 13 | KANDA ENTERPRISES | 205652.00 | L1 | Qualified |
| 14 | NUYOS HEALTHCARE PRIVATE LIMITED | 206778.24 | L2 | Qualified |
| 15 | SANMAK PHARMACEUTICALS PRIVATE LIMITED | 234172.00 | L3 | Qualified |
| 16 | KANDA ENTERPRISES | 205652.00 | L1 | Qualified |
| 17 | NUYOS HEALTHCARE PRIVATE LIMITED | 206778.24 | L2 | Qualified |
| 18 | SANMAK PHARMACEUTICALS PRIVATE LIMITED | 234172.00 | L3 | Qualified |
| 19 | KANDA ENTERPRISES | 205652.00 | L1 | Qualified |
| 20 | NUYOS HEALTHCARE PRIVATE LIMITED | 206778.24 | L2 | Qualified |
| 21 | SANMAK PHARMACEUTICALS PRIVATE LIMITED | 234172.00 | L3 | Qualified |
| 22 | KANDA ENTERPRISES | 205652.00 | L1 | Qualified |
| 23 | NUYOS HEALTHCARE PRIVATE LIMITED | 206778.24 | L2 | Qualified |
| 24 | SANMAK PHARMACEUTICALS PRIVATE LIMITED | 234172.00 | L3 | Qualified |
| 25 | KANDA ENTERPRISES | 205652.00 | L1 | Qualified |
| 26 | NUYOS HEALTHCARE PRIVATE LIMITED | 206778.24 | L2 | Qualified |
| 27 | SANMAK PHARMACEUTICALS PRIVATE LIMITED | 234172.00 | L3 | Qualified |
| 28 | KANDA ENTERPRISES | 205652.00 | L1 | Qualified |
| 29 | NUYOS HEALTHCARE PRIVATE LIMITED | 206778.24 | L2 | Qualified |
| 30 | SANMAK PHARMACEUTICALS PRIVATE LIMITED | 234172.00 | L3 | Qualified |
| 31 | KANDA ENTERPRISES | 205652.00 | L1 | Qualified |
| 32 | NUYOS HEALTHCARE PRIVATE LIMITED | 206778.24 | L2 | Qualified |
| 33 | SANMAK PHARMACEUTICALS PRIVATE LIMITED | 234172.00 | L3 | Qualified |